TR200201211T2 - Methods and compositions for the treatment of pulmonary diseases. - Google Patents

Methods and compositions for the treatment of pulmonary diseases.

Info

Publication number
TR200201211T2
TR200201211T2 TR2002/01211T TR200201211T TR200201211T2 TR 200201211 T2 TR200201211 T2 TR 200201211T2 TR 2002/01211 T TR2002/01211 T TR 2002/01211T TR 200201211 T TR200201211 T TR 200201211T TR 200201211 T2 TR200201211 T2 TR 200201211T2
Authority
TR
Turkey
Prior art keywords
treatment
compositions
methods
pulmonary diseases
diseases
Prior art date
Application number
TR2002/01211T
Other languages
Turkish (tr)
Inventor
N. Goodfellow Peter
Nieman Richard
J. Torphy Theodore
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200201211T2 publication Critical patent/TR200201211T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Bu bulus, bir anti-enflamatuvar kortikosteroid ile kombinasyon halinde bir fosfodiesteraz 4 inhibitörünün uygulanmasi ile kronik obstrüktif pulmoner hastalik veya astim gibi pulmoner hastaliklarin tedavisi ile ilgilidir.This invention relates to the administration of a phosphodiesterase 4 inhibitor in combination with an anti-inflammatory corticosteroid and the treatment of pulmonary diseases such as chronic obstructive pulmonary disease or asthma.

TR2002/01211T 1999-11-02 2000-11-01 Methods and compositions for the treatment of pulmonary diseases. TR200201211T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
TR200201211T2 true TR200201211T2 (en) 2002-08-21

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01211T TR200201211T2 (en) 1999-11-02 2000-11-01 Methods and compositions for the treatment of pulmonary diseases.

Country Status (29)

Country Link
EP (1) EP1225866A4 (en)
JP (1) JP2003513028A (en)
KR (1) KR20020057988A (en)
CN (1) CN1387404A (en)
AP (1) AP2002002496A0 (en)
AR (1) AR029189A1 (en)
AU (1) AU1357501A (en)
BG (1) BG106748A (en)
BR (1) BR0015270A (en)
CA (1) CA2388333A1 (en)
CO (1) CO5261512A1 (en)
CZ (1) CZ20021512A3 (en)
DZ (1) DZ3225A1 (en)
EA (1) EA200200518A1 (en)
EC (1) ECSP003747A (en)
HK (1) HK1049107A1 (en)
HU (1) HUP0203152A3 (en)
IL (1) IL149367A0 (en)
MA (1) MA26841A1 (en)
MX (1) MXPA02004350A (en)
NO (1) NO20022057L (en)
OA (1) OA12076A (en)
PE (1) PE20011005A1 (en)
PL (1) PL355261A1 (en)
SK (1) SK7592002A3 (en)
TR (1) TR200201211T2 (en)
TW (1) TWI242431B (en)
WO (1) WO2001032127A2 (en)
ZA (1) ZA200203435B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4588998B2 (en) 2001-09-19 2010-12-01 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Concomitant medication
HUP0401984A3 (en) * 2001-10-31 2005-06-28 Merck Patent Gmbh Use of type 4 phosphodiesterase inhibitors for preparation of pharmaceutical compositions and combination with other active ingredients
UA82323C2 (en) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
EP1616569A1 (en) * 2003-03-31 2006-01-18 Kyowa Hakko Kogyo Co., Ltd. Medicinal composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
JP6017961B2 (en) 2010-01-05 2016-11-02 マイクロドース セラピューテクス，インコーポレイテッド Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0710109T1 (en) * 1993-06-18 2005-02-28 Smithkline Beecham Corporation Method for identifying a PDE IV inhibitor
DE4332041C2 (en) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Use of pentoxifylline in certain lung diseases
PE44995A1 (en) * 1994-01-27 1995-12-18 Schering Corp MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
SE9801368D0 (en) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
MXPA02004350A (en) 2002-11-07
PE20011005A1 (en) 2001-09-28
AR029189A1 (en) 2003-06-18
NO20022057D0 (en) 2002-04-30
JP2003513028A (en) 2003-04-08
WO2001032127A3 (en) 2001-12-06
IL149367A0 (en) 2002-11-10
BR0015270A (en) 2002-06-18
MA26841A1 (en) 2004-12-20
OA12076A (en) 2006-05-04
CA2388333A1 (en) 2001-05-10
AU1357501A (en) 2001-05-14
BG106748A (en) 2003-02-28
EA200200518A1 (en) 2002-10-31
CZ20021512A3 (en) 2003-04-16
WO2001032127A2 (en) 2001-05-10
SK7592002A3 (en) 2002-11-06
CN1387404A (en) 2002-12-25
EP1225866A4 (en) 2004-04-21
DZ3225A1 (en) 2001-05-10
AP2002002496A0 (en) 2002-06-30
PL355261A1 (en) 2004-04-05
HUP0203152A2 (en) 2003-01-28
CO5261512A1 (en) 2003-03-31
ECSP003747A (en) 2002-05-23
ZA200203435B (en) 2003-06-25
TWI242431B (en) 2005-11-01
HUP0203152A3 (en) 2004-06-28
EP1225866A2 (en) 2002-07-31
HK1049107A1 (en) 2003-05-02
NO20022057L (en) 2002-06-27
KR20020057988A (en) 2002-07-12

Similar Documents

Publication Publication Date Title
UY28958A1 (en) NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA
ATE486840T1 (en) MODIFIED FORMS OF PHARMACEUTICALLY ACTIVE AGENTS AND USES THEREOF
ATE277929T1 (en) IMMUNOSUPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES
BRPI0411825A (en) 5-element heterocycle-based p38 kinase inhibitors
NO20060328L (en) Combination of mGluR2 antagonist and ACHE inhibitor for the treatment of acute and / or chronic neurological disorders
TR200102110T2 (en) Combinations of formoterol and fluicasone propionate for asthma.
BRPI0407922A (en) isoquinoline derivatives and methods of use of these
CY1108274T1 (en) GLUCOGENIC Peptide 2 (GLP-2) -LABORATORY FOR GASTRENTAL DISEASE AND DISORDER TREATMENT
WO2001083554A3 (en) Anti-inflammatory compounds and uses thereof
EA200300293A1 (en) ANTI-INFLAMMATORY CONDENSED Pyrrolocarbazoles
CY1105225T1 (en) 5-B-SAPOGENIN AND PSEUDOSAPOGENIN DERIVATIVES AND THEIR USE IN THE TREATMENT OF DEMENTIA
MXPA04000793A (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma.
TR200201211T2 (en) Methods and compositions for the treatment of pulmonary diseases.
WO2000045800A3 (en) Immunosurpressive effects of pteridine derivatives
MXPA03008423A (en) Nicotinic receptor agonists for the treatment of inflammatory diseases.
EA200201276A1 (en) ARYLMETYLAMINE DERIVATIVES FOR USE AS TRIPTASE INHIBITORS
SE9900833D0 (en) Novel combination
MXPA05009986A (en) Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders.
TR200000907T2 (en) Pyrolopirolone derivatives as neutrophil elastase inhibitors.
PT1268472E (en) 3-AMINOPIRAZOLIC INHIBITORS OF CYCLINE DEPENDENT KINASES
TR200102448T2 (en) Controlled release formulation for COPD treatment.
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
SE9900834D0 (en) Novel combination
HUP0301257A2 (en) Combined compositions against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase i and ii inhibitors
BR9910696A (en) Pharmaceutical compositions